Clinical Trial Detail

Clinical Trials

Clinical Trial Detail

UVADEX® and ECP for the Treatment of Pediatric Patients With Steroid Refractory Acute Graft Versus Host Disease

Complete title: Single-Arm Study to Assess the Efficacy of UVADEX(R) (methoxsalen) Sterile Solution in Conjunction With THERAKOS(R) CELLEX(R) Photopheresis Systems in Pediatric Patients With Steroid-Refractory Acute Graft Versus Host Disease (aGvHD)

Research Study Number 9550
 
Principal Investigator Paul Carpenter, MD
 
Phase III

Research Study Description

This is a single-arm, open-label, multicenter study of the efficacy of UVADEX® (methoxsalen) Sterile Solution in conjunction with THERAKOS® CELLEX® Photopheresis Systems in pediatric patients with steroid-refractory aGvHD. The study is composed of Screening, Treatment, and Follow-up Periods.

Eligibility Criteria (must meet the following to participate in this study)

** For Eligibility information, please click on the "Look up trial at NIH" link above. **

Other eligibility criteria may apply.

Research Study Number 9550
 
Contact Seattle Cancer Care Alliance Intake Office
 
Telephone 800-804-8824 / 206-606-1024
 

Keywords: Graft Versus Host Disease (GVHD); Graft Versus Host Disease, Acute (aGVHD); Immune System Diseases; Immunotherapy

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials